The development and implementation of a rapid-access long-acting injectable buprenorphine clinic in metropolitan Melbourne during the COVID-19 pandemic

Drug Alcohol Rev. 2021 May;40(4):681-682. doi: 10.1111/dar.13161. Epub 2020 Sep 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Ambulatory Care Facilities / trends*
  • Buprenorphine / administration & dosage*
  • COVID-19 / epidemiology*
  • Delayed-Action Preparations / administration & dosage
  • Humans
  • Narcotic Antagonists / administration & dosage*
  • Opiate Substitution Treatment / methods
  • Opiate Substitution Treatment / trends*
  • Opioid-Related Disorders / drug therapy*
  • Opioid-Related Disorders / epidemiology
  • Victoria / epidemiology

Substances

  • Delayed-Action Preparations
  • Narcotic Antagonists
  • Buprenorphine

Grants and funding